Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
15 Jul - 16 Dec 1981
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study without detailed documentation

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1983
Report date:
1983

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
1981
Deviations:
no
Qualifier:
according to guideline
Guideline:
EPA OPP 81-2 (Acute Dermal Toxicity)
Version / remarks:
1978
Deviations:
no
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Diethyl bis(2-hydroxyethyl)aminomethylphosphonate
EC Number:
220-482-8
EC Name:
Diethyl bis(2-hydroxyethyl)aminomethylphosphonate
Cas Number:
2781-11-5
Molecular formula:
C9H22NO5P
IUPAC Name:
diethyl {[bis(2-hydroxyethyl)amino]methyl}phosphonate
Test material form:
liquid: viscous
Details on test material:
- Physical state: viscous liquid
- Colour: amber
- Expiry date: not reported
Specific details on test material used for the study:
- Receipt date: 25 Jun 1981
- Color: amber
- Form: viscous liquid

Test animals

Species:
rabbit
Strain:
other: Stauffland albino rabbits
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Phillips Rabbitry, Soquel, USA
- Weight at study initiation: 1.550-1.866 kg


Administration / exposure

Type of coverage:
not specified
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: abdominal skin
- Treatment of skin: abration of skin on half of the test animals
- Type of wrap: protective binder (during treatment with test material), gauze binder (during 14-day follow-up period)

REMOVAL OF TEST SUBSTANCE
- Time after start of exposure: 24 h

TEST MATERIAL
- Amount applied: 2000 mg/kg bw
- Constant volume or concentration used: yes

Duration of exposure:
24 h
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
5 males and females per dose and 2 males and females per control
Control animals:
yes
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: minimally twice a day; only once a day on holidays and weekends
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, organ weights, histopathology

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality occurred during the study period.
Clinical signs:
other: other: Mild depression in all rabbits; one rabbit with diarrhea.
Gross pathology:
Necropsy and histopathological examination revealed no substance-related findings.
Other findings:
- Local dermal effects: mild erythema and edema

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the test conditions, the test material is not classified according to Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
Executive summary:

In an acute dermal toxicity study performed according to the OECD TG 402, groups of Stauffland albino rabbits (5/sex) were dermally exposed to the undiluted test material for 24 hours to abraded and unabraded abdominal skin at doses of 2000 mg/kg bw. Animals then were observed for 14 days.


 


No mortality occurred during the study period. The only adverse clinical sign in all rabbits was mild depression. One rabbit had diarrhea.


Necropsy and histopathological examination revealed no substance-related findings.


Local dermal effects included mild erythema and edema.


 


Combined Dermal LD50  > 2000 mg/kg bw


Under the test conditions, the test material is not classified according to Regulation (EC) No. 1272/2008 (CLP) and to the GHS.